Using Technology to Deliver Complex Oncology Trials

The enormous investment in oncology research reflects cancer’s major societal impacts, the commercial benefits of successful treatments and the still-elusive goal of broad eradication. The need for cancer drugs is substantial, as is the effort being expended in the commercial and non-profit arenas. The rewards for success are socially, politically and financially vast, yet these are matched by challenges in scale and difficulty. Oncology clinical trials are widely recognized as being among the most complex trials to design, set up, execute and deliver.

The white paper describes how advanced technology, built on modern computer technology and standards-based architectures, can address these issues. Case studies illustrate how this new technology can help resolve the implementation and structural problems inherent in this critical research area.

请注册以阅读全文